Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base

AIDS

Volumn 17, Issue 5, 2003, Pages 685-689

  Cavacini, Lisa ^a,b   Duval, Mark ^a   Song, Leslie ^a   Sangster, Rebecca ^a   Xiang, Shi Hua ^b,c   Sodroski, Joseph ^b,c,d   Posner, Marshall ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Conformational changes; env oligomer; Monoclonal antibody

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G2; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY B4E8; OLIGOMER; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; ENVELOPE GENE; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

ANTIBODIES, MONOCLONAL; CELLS, CULTURED; EPITOPES; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; VIRION;

EID: 0037471318     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200303280-00006     Document Type: Article

References (32)

1. Wyatt R, Kwong P, Desjardins E, Sweet R, Robinson J, Hendrickson W, et al. The antigenic structure of HIV gp120 envelope glycoprotein. Nature 1998, 393:705-711.
2. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 1998, 280:1884-1888.
3. Rizzuto C, Wyatt R, Hernandez-Ramos N, Sun Y, Kwong PD, Hendrickson WA, et al. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998, 280:1949-1953.
4. Kwong P, Wyatt R, Robinson J, Sweet R, Sodroski J, Hendrickson W. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998, 393:648-659.
5. Binley J, Wyatt R, Desjardins E, Kwong PD, Hendrickson WA, Moore JP, et al. Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. AIDS Res Hum Retroviruses 1998, 14:191-198.
6. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995, 69:5723-5733.
7. Wyatt R, Sullivan N, Thali M, Repke H, Ho D, Robinson J, et al. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J Virol 1993, 67:4557-4565.
8. Cao J, Sullivan N, Desjardin E, Parolin C, Robinson J, Wyatt R, et al. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol 1997, 71:9808-9812.
9. Center R, Earl P, Lebowitz J, Schuck P, Moss B. The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts. J Virol 2000, 74:4448-4455.
10. Thali M, Moore J, Furman C, Charles M, Ho DD, Robinson J, et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993, 67:3978-3988.
11. Sullivan N, Sun Y, Sattentau Q, Thali M, Wu D, Denisova G, et al. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization. J Virol 1998, 72:4694-4703.
12. Kolchinsky P, Kiprilov E, Bartley P, Rubinstein R, Sodroski J. Loss of a single N-linked glycan allows CD4 independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. J Virol 2001, 75:3435-3443.
13. Ogert R, Lee M, Ross W, Buckler-White A, Martin M, Cho M. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 2001, 75:5998-6006.
14. Losman B, Bolmstedt A, Schonning K, Bjorndal A, Westin C, Fenyo EM, et al. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region. AIDS Res Hum Retroviruses 2001, 17:1067-1076.
15. Posner M, Elboim H, Santos D. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies. Hybridoma 1987, 6:611-625.
16. Posner M, Barrach H, Elboim HS, Nevins K, Santos DJ, Chichester CO, et al. The generation of hybridomas secreting human monoclonal antibodies reactive with type II collagen. Hybridoma 1989, 8:187-197.
17. Cavacini L, Emes C, Wisenewski A, Power J, Lewis G, Montefiori D, et al. Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV-1/gp41. AIDS Res Hum Retroviruses 1998, 14:1271-1280.
18. Cavacini LA, Wisnewski A, Peterson JE, Montefiori D, Emes C, Duval M, et al. A human anti-HIV autoantibody enhances EBV transformation and HIV infection. Clin Immunol 1999, 93:263-273.
19. Cavacini L, Peterson J, Nappi E, Duval M, Goldstein R, Mayer K, et al. Minimal incidence of serum antibodies reactive with intact primary isolate virions in HIV-1 infected individuals. J Virol 1999, 73:9638-9641.
20. Cavacini L, Samore M, Gambertoglio J, Duval M, Wisnewski A, Hammer S, et al. Phase I study of a human monoclonal antibody against the CD4 binding site of HIV-1/gp120. AIDS Res Hum Retroviruses 1998, 14:545-550.
21. Cavacini L, Duval M, Robinson J, Posner M. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate virions. AIDS 2002, 16:2409-2417.
22. Cavacini L, Emes C, Power J, Buchbinder A, Zolla-Pazner S, Posner M. Human monoclonal antibodies to the V3 Loop of gp120 mediate variable and distinct effects on binding and viral neutralization by a human monoclonal antibody to the CD4 binding site. J Acquir Immune Defic Syndr 1993, 6:353-358.
23. Nyambi P, Miroslaw G, Bastini L, Van Der Groen G, Williams C, Zolla-Pazner S. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J Virol 1998, 72:9384-9391.
24. Nyambi P, Mbah H, Burda S, Williams C, Gorny MK, Nadas A, et al. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J Virol 2000, 74:7096-7107.
25. Stamatatos L, Cheng-Mayer C. An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades. J Virol 1998, 72:7840-7845.
26. Wyatt R, Desjardin E, Olshevsky U, Nixon C, Binley J, Olshevsky V, et al. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. J Virol 1997, 71:9722-9731.
27. Bou-Habib D, Roderiquez G, Oravecz T, Berman P, Lusso P, Norcross M. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J Virol 1994, 68:6006-6013.
28. Thali M, Furman C, Wahren B, Posner M, Ho D, Robinson J, et al. Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the Human Immunodeficiency Virus gp120 envelope glycoprotein. J Acquir Immune Defic Syndr 1992, 5:591-599.
29. Spenlehauer C, Saragosti S, Fleury H, Kirn A, Aubertin A, Moog C. Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1. J Virol 1998, 72:9855-9864.
30. Schonning K, Jansson B, Olofsson S, Nielsen J, Hansen J-E. Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer. Virology 1996, 218:134-140.
31. Schonning K, Bolmstedt A, Novotny J, Lund O, Olofsson S, Hansen J-E. Induction of antibodies against epitopes inaccessible on the HIv type 1 envelope oligomer by immunization with recombinant monomeric glycoprotein 120. AIDS Res Hum Retroviruses 1998, 14:1451-1456.
32. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 1996, 70:1100-1108.